Quebec’s Plan to Protect Abortion Rights
Quebec's government introduced a $7.5-million plan to improve abortion access and counter global threats to women's rights. The plan includes enhancing services outside Montreal, expanding telehealth, and opening new clinics, all in response to rising anti-choice movements following the U.S. Supreme Court's Roe v. Wade decision.
E. coli Contamination in Organic Carrots
The CFIA has issued a nationwide recall for organic carrots from brands like Compliments and President's Choice due to E. coli contamination. Affected products have best-before dates from Aug. 14 to Nov. 12. Consumers are advised to discard or return recalled items for a refund.
Lifestyle Factors Linked to Healthier Cognitive Aging
A study on Scottish adults suggests early cognitive abilities may influence cognitive aging. Lifestyle factors—exercise, avoiding smoking, bilingualism, and musical activity—contribute slightly to cognitive health. MRI scans at age 73 reveal notable brain health variations, showing that cognitive decline isn’t inevitable and may be managed by lifestyle choices.
Health Risks of Extended Toilet Sitting with Phones
Using phones while on the toilet extends sitting time, leading to risks like hemorrhoids, weakened pelvic muscles, and rectal prolapse, warns Dr. Lai Xue. Prolonged sitting disrupts blood flow due to gravity. Experts advise reducing bathroom time and avoiding devices to prevent health issues and support digestive health.
Canada’s First Human Case of Bird Flu: Teen in Critical Condition
A teenager in Canada, suspected to have the country's first human H5N1 avian flu case, is in critical condition with acute respiratory distress at BC Children’s Hospital. Health authorities are investigating possible exposure sources, though no farm connection has been found. Contacts are being tested, and health officials advise caution around sick birds.
Brain-Stimulating Headset Shows Promise for Depression Relief
A wearable brain-zapping device from Flow Neuroscience could help treat depression, according to a study in Nature Medicine. The study found 45% of users experienced depression remission after ten weeks. The device, pending U.S. FDA approval, targets specific brain regions to rebalance activity and improve mood symptoms.